Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 8.90x is 68% below its estimated 2-year average of 27.85x, near the low end of its estimated 2-year range (1.51x–153.76x).
As of 2026-10-06T19:28:25.611Z. 48.00% below its estimated 12-month average of 17.11x.
Calculation as of: 2026-10-06T19:28:25.611Z.
Quote observation: 2026-10-06T19:25:15.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f896dd83f1f74da7f4e84885d6bb04cd833df246353afdbeec9bf8c0bdc7d1c4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
8.90x
EV/SALES RATIO AVG TTM
17.11x
EV/SALES RATIO AVG 3Y
27.85x
EV/SALES RATIO AVG 5Y
27.85x
EV/SALES RATIO AVG 10Y
N/A
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-48.00%
CURRENT VS 3Y AVG
-68.05%
CURRENT VS 5Y AVG
-68.05%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.38x
median of 549 covered companies
CURRENT VS SECTOR MEDIAN
+103.20%
vs the sector median at left
X4 Pharmaceuticals, Inc.
Market Cap
$258.91M
EV/Sales Ratio
8.90x
TTM Avg
17.11x
3Y Avg
27.85x
5Y Avg
27.85x
Market Cap
$259.30M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$262.00M
EV/Sales Ratio
62.36x
TTM Avg
74.23x
3Y Avg
31.36x
5Y Avg
21.18x
Market Cap
$261.62M
EV/Sales Ratio
1.01x
TTM Avg
0.74x
3Y Avg
0.47x
5Y Avg
0.82x
Market Cap
$260.30M
EV/Sales Ratio
N/A
TTM Avg
495.70x
3Y Avg
495.70x
5Y Avg
495.70x
Market Cap
$256.98M
EV/Sales Ratio
10.49x
TTM Avg
42.40x
3Y Avg
29706.49x
5Y Avg
21359.19x
Market Cap
$256.62M
EV/Sales Ratio
2.00x
TTM Avg
1.60x
3Y Avg
1.66x
5Y Avg
1.91x
Market Cap
$264.36M
EV/Sales Ratio
1.58x
TTM Avg
1.20x
3Y Avg
2.37x
5Y Avg
5.33x
Market Cap
$263.84M
EV/Sales Ratio
277.34x
TTM Avg
543.80x
3Y Avg
374.50x
5Y Avg
374.50x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| X4 Pharmaceuticals, Inc. (XFOR) | $258.91M | 8.90x | 17.11x | 27.85x | 27.85x |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.30M | N/A | N/A | N/A | N/A |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $262.00M | 62.36x | 74.23x | 31.36x | 21.18x |
| OraSure Technologies, Inc. (OSUR)vs › | $261.62M | 1.01x | 0.74x | 0.47x | 0.82x |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $260.30M | N/A | 495.70x | 495.70x | 495.70x |
| AC Immune S.A. (ACIU)vs › | $256.98M | 10.49x | 42.40x | 29706.49x | 21359.19x |
| Anika Therapeutics, Inc. (ANIK)vs › | $256.62M | 2.00x | 1.60x | 1.66x | 1.91x |
| Treace Medical Concepts, Inc. (TMCI)vs › | $264.36M | 1.58x | 1.20x | 2.37x | 5.33x |
| Palisade Bio, Inc. (PALI)vs › | $263.84M | 277.34x | 543.80x | 374.50x | 374.50x |
| Scribe Therapeutics Inc. (SCTX)vs › | $265.14M | N/A | N/A | N/A | N/A |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 15.68x |
| 2026-10-02 | 15.12x |
| 2026-10-01 | 15.12x |
| 2026-09-30 | 15.68x |
| 2026-09-29 | 15.68x |
| 2026-09-28 | 16.64x |
| 2026-09-25 | 16.56x |
| 2026-09-24 | 16.48x |
| 2026-09-23 | 17.36x |
| 2026-09-22 | 19.91x |
| 2026-09-21 | 20.47x |
| 2026-09-18 | 21.10x |
| 2026-09-17 | 20.47x |
| 2026-09-16 | 20.55x |
| 2026-09-15 | 21.42x |
| 2026-09-14 | 21.42x |
| 2026-09-11 | 20.47x |
| 2026-09-10 | 19.67x |
| 2026-09-09 | 21.26x |
| 2026-09-08 | 20.55x |
| 2026-09-04 | 24.77x |
| 2026-09-03 | 24.77x |
| 2026-09-02 | 24.77x |
| 2026-09-01 | 25.01x |
| 2026-08-31 | 24.77x |
| 2026-08-28 | 24.77x |
| 2026-08-27 | 26.29x |
| 2026-08-26 | 25.81x |
| 2026-08-25 | 25.73x |
| 2026-08-24 | 24.85x |
| 2026-08-21 | 24.77x |
| 2026-08-20 | 24.69x |
| 2026-08-19 | 25.73x |
| 2026-08-18 | 26.13x |
| 2026-08-17 | 26.84x |
| 2026-08-14 | 26.21x |
| 2026-08-13 | 26.76x |
| 2026-08-12 | 26.76x |
| 2026-08-11 | 26.69x |
| 2026-08-10 | 26.45x |
| 2026-08-07 | 29.56x |
| 2026-08-06 | 42.93x |
| 2026-08-05 | 42.65x |
| 2026-08-04 | 44.61x |
| 2026-08-03 | 41.81x |
| 2026-07-31 | 40.27x |
| 2026-07-30 | 40.55x |
| 2026-07-29 | 40.55x |
| 2026-07-28 | 39.57x |
| 2026-07-27 | 39.71x |
| 2026-07-24 | 38.45x |
| 2026-07-23 | 40.41x |
| 2026-07-22 | 36.34x |
| 2026-07-21 | 36.20x |
| 2026-07-20 | 36.06x |
| 2026-07-17 | 38.03x |
| 2026-07-16 | 38.17x |
| 2026-07-15 | 39.15x |
| 2026-07-14 | 40.83x |
| 2026-07-13 | 41.25x |
| 2026-07-10 | 46.29x |
| 2026-07-09 | 39.99x |
| 2026-07-08 | 39.99x |
| 2026-07-07 | 39.71x |
| 2026-07-06 | 40.97x |
| 2026-07-02 | 42.37x |
| 2026-07-01 | 41.81x |
| 2026-06-30 | 49.93x |
| 2026-06-29 | 43.77x |
| 2026-06-26 | 40.83x |
| 2026-06-25 | 40.41x |
| 2026-06-24 | 41.81x |
| 2026-06-23 | 40.55x |
| 2026-06-22 | 42.23x |
| 2026-06-18 | 43.63x |
| 2026-06-17 | 41.25x |
| 2026-06-16 | 41.11x |
| 2026-06-15 | 41.67x |
| 2026-06-12 | 40.55x |
| 2026-06-11 | 38.87x |
| 2026-06-10 | 36.77x |
| 2026-06-09 | 38.45x |
| 2026-06-08 | 36.49x |
| 2026-06-05 | 38.17x |
| 2026-06-04 | 40.69x |
| 2026-06-03 | 40.13x |
| 2026-06-02 | 41.11x |
| 2026-06-01 | 42.09x |
| 2026-05-29 | 44.89x |
| 2026-05-28 | 42.51x |
| 2026-05-27 | 40.97x |
| 2026-05-26 | 40.55x |
| 2026-05-22 | 41.11x |
| 2026-05-21 | 41.11x |
| 2026-05-20 | 37.33x |
| 2026-05-19 | 35.50x |
| 2026-05-18 | 36.06x |
| 2026-05-15 | 39.71x |
| 2026-05-14 | 40.55x |
| 2026-05-13 | 43.77x |
| 2026-05-12 | 45.31x |
| 2026-05-11 | 47.55x |
| 2026-05-08 | 46.57x |
| 2026-05-07 | 44.61x |
| 2026-05-06 | 9.81x |
| 2026-05-05 | 9.24x |
| 2026-05-04 | 9.28x |
| 2026-05-01 | 9.21x |
| 2026-04-30 | 8.83x |
| 2026-04-29 | 8.93x |
| 2026-04-28 | 8.99x |
| 2026-04-27 | 9.28x |
| 2026-04-24 | 8.96x |
| 2026-04-23 | 9.50x |
| 2026-04-22 | 9.94x |
| 2026-04-21 | 9.15x |
| 2026-04-20 | 9.21x |
| 2026-04-17 | 9.53x |
| 2026-04-16 | 9.05x |
| 2026-04-15 | 9.65x |
| 2026-04-14 | 9.24x |
| 2026-04-13 | 9.02x |
| 2026-04-10 | 8.93x |
| 2026-04-09 | 8.83x |
| 2026-04-08 | 8.77x |
| 2026-04-07 | 7.76x |
| 2026-04-06 | 8.83x |
| 2026-04-02 | 9.37x |
| 2026-04-01 | 9.72x |
| 2026-03-31 | 9.02x |
| 2026-03-30 | 8.58x |
| 2026-03-27 | 8.74x |
| 2026-03-26 | 9.59x |
| 2026-03-25 | 8.90x |
| 2026-03-24 | 8.05x |
| 2026-03-23 | 8.83x |
| 2026-03-20 | 9.50x |
| 2026-03-19 | 9.15x |
| 2026-03-18 | 8.77x |
| 2026-03-17 | 5.61x |
| 2026-03-16 | 4.76x |
| 2026-03-13 | 4.93x |
| 2026-03-12 | 5.17x |
| 2026-03-11 | 5.74x |
| 2026-03-10 | 6.16x |
| 2026-03-09 | 5.51x |
| 2026-03-06 | 5.02x |
| 2026-03-05 | 4.94x |
| 2026-03-04 | 4.68x |
| 2026-03-03 | 4.47x |
| 2026-03-02 | 4.56x |
| 2026-02-27 | 4.61x |
| 2026-02-26 | 4.37x |
| 2026-02-25 | 4.61x |
| 2026-02-24 | 4.54x |
| 2026-02-23 | 4.25x |
| 2026-02-20 | 4.25x |
| 2026-02-19 | 4.18x |
| 2026-02-18 | 4.04x |
| 2026-02-17 | 4.18x |
| 2026-02-13 | 4.57x |
| 2026-02-12 | 4.52x |
| 2026-02-11 | 4.60x |
| 2026-02-10 | 4.95x |
| 2026-02-09 | 4.75x |
| 2026-02-06 | 4.76x |
| 2026-02-05 | 4.89x |
| 2026-02-04 | 5.13x |
| 2026-02-03 | 5.32x |
| 2026-02-02 | 5.30x |
| 2026-01-30 | 4.94x |
| 2026-01-29 | 4.93x |
| 2026-01-28 | 4.84x |
| 2026-01-27 | 4.94x |
| 2026-01-26 | 4.85x |
| 2026-01-23 | 4.94x |
| 2026-01-22 | 5.02x |
| 2026-01-21 | 5.00x |
| 2026-01-20 | 4.90x |
| 2026-01-16 | 4.94x |
| 2026-01-15 | 4.84x |
| 2026-01-14 | 5.03x |
| 2026-01-13 | 5.16x |
| 2026-01-12 | 5.19x |
| 2026-01-09 | 5.32x |
| 2026-01-08 | 5.37x |
| 2026-01-07 | 5.32x |
| 2026-01-06 | 5.27x |
| 2026-01-05 | 5.12x |
| 2026-01-02 | 5.18x |
| 2025-12-31 | 5.32x |
| 2025-12-30 | 5.53x |
| 2025-12-29 | 5.70x |
| 2025-12-26 | 5.96x |
| 2025-12-24 | 5.86x |
| 2025-12-23 | 5.47x |
| 2025-12-22 | 5.45x |
| 2025-12-19 | 4.81x |
| 2025-12-18 | 4.89x |
| 2025-12-17 | 4.70x |
| 2025-12-16 | 4.95x |
| 2025-12-15 | 5.02x |
| 2025-12-12 | 5.21x |
| 2025-12-11 | 5.17x |
| 2025-12-10 | 5.18x |
| 2025-12-09 | 4.86x |
| 2025-12-08 | 5.12x |
| 2025-12-05 | 5.30x |
| 2025-12-04 | 5.07x |
| 2025-12-03 | 4.37x |
| 2025-12-02 | 4.30x |
| 2025-12-01 | 4.24x |
| 2025-11-28 | 4.86x |
| 2025-11-26 | 4.86x |
| 2025-11-25 | 5.07x |
| 2025-11-24 | 5.07x |
| 2025-11-21 | 5.00x |
| 2025-11-20 | 4.94x |
| 2025-11-19 | 4.88x |
| 2025-11-18 | 4.81x |
| 2025-11-17 | 4.89x |
| 2025-11-14 | 4.89x |
| 2025-11-13 | 4.98x |
| 2025-11-12 | 5.16x |
| 2025-11-11 | 4.72x |
| 2025-11-10 | 4.85x |
| 2025-11-07 | 4.95x |
| 2025-11-06 | 4.70x |
| 2025-11-05 | 1.99x |
| 2025-11-04 | 2.08x |
| 2025-11-03 | 2.11x |
| 2025-10-31 | 2.10x |
| 2025-10-30 | 2.09x |
| 2025-10-29 | 2.03x |
| 2025-10-28 | 2.05x |
| 2025-10-27 | 2.03x |
| 2025-10-24 | 2.04x |
| 2025-10-23 | 1.88x |
| 2025-10-22 | 1.89x |
| 2025-10-21 | 1.89x |
| 2025-10-20 | 1.89x |
| 2025-10-17 | 1.86x |
| 2025-10-16 | 1.86x |
| 2025-10-15 | 1.83x |
| 2025-10-14 | 1.86x |
| 2025-10-13 | 1.88x |
| 2025-10-10 | 1.88x |
| 2025-10-09 | 1.96x |
| 2025-10-08 | 1.93x |
| 2025-10-07 | 1.96x |
| 2025-10-06 | 1.95x |
| 2025-10-03 | 1.97x |
| 2025-10-02 | 1.97x |
| 2025-10-01 | 2.00x |
| 2025-09-30 | 1.96x |
| 2025-09-29 | 1.94x |
| 2025-09-26 | 1.97x |
| 2025-09-25 | 1.95x |
| 2025-09-24 | 1.99x |
| 2025-09-23 | 1.96x |
Showing the most recent 260 of 790 data points. The chart above shows the full history.
